Skip to main content

Table 2 Minimum inhibitory concentrations (MIC µg/mL) for clinical isolates of compounds (10), (13), (14), (16), (25) and (30)

From: Synthesis, characterization and evaluation of 1,3,5-triazine aminobenzoic acid derivatives for their antimicrobial activity

Test compound

MRSA

E. coli

Ampicillin

>200

>200

10

25

100

13

100

25

14

>200

100

16

100

>200

25

100

100

30

>200

>200

  1. MRSA methicillin-resistant Staphylococcus aureus
Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us